caterina casari
53
Documents
Affiliation actuelle
- Hémostase, Inflammation, Thrombose (HITH - U1176 Inserm - CHU Bicêtre)
Identifiants chercheurs
Présentation
I am a tenured researcher in France at the Inserm Unit 1176, Hemostasis, Inflammation and Thrombosis laboratory. My research studies focus on von Willebrand factor and its partners. I am interested in developing in vitro & in vivo models to elucidate molecular mechanisms underlying unsolved clinical aspects of congenital and acquired von Willebrand disease. I am also interested in exploring new therapeutic approaches for VWF-associated disorders.
Domaines de recherche
Sciences du Vivant [q-bio]
Publications
Publications
Novel VWD TreatmentWFH Comprehensive Core Summit, Apr 2025, Dubai, United Arab Emirates. Haemophilia, 2025, ⟨10.1111/hae.70031⟩
Proceedings/Recueil des communications
hal-05051691
v1
|
A consistent in vivo factor VIII-equivalence is unlikely to exist for non-factor therapiesCongrès Français d'Hémostase, Société Française de Thrombose et d'Hémostase, Sep 2024, Lille, France
Communication dans un congrès
hal-04701045
v1
|
|
Fitusiran-treatment modulates the ratio between alpha- and beta-antithrombin isoformsCongrès Français d'Hémostase, Société Française de Thrombose et d'Hémostase, Sep 2024, Lille, France
Communication dans un congrès
hal-04701035
v1
|
|
|
|
Future therapies for von Willebrand disease16th European Association for Haemophilia and Allied Disorders (EAHAD), Feb 2023, Manchester, United Kingdom. pp.5-13, ⟨10.1111/hae.14713⟩
Communication dans un congrès
hal-04459575
v1
|
|
|
Novel Therapeutics for VWDInternational Society of Thrombosis and Haemostasis ISTH, Jun 2023, Montreal, Canada. ⟨10.1016/j.rpth.2023.100193⟩
Communication dans un congrès
hal-04459623
v1
|
Antibodies for VWDEHC Workshop in New technologies in rare bleeding disorders, Nov 2023, Cascais, Portugal
Communication dans un congrès
hal-04459657
v1
|
|
Update on KB-V13A12 & SynthoPlatesEHC Workshop in New technologies in rare bleeding disorders, Nov 2023, Cascais, Portugal
Communication dans un congrès
hal-04459645
v1
|
|
Bon vent pour les patients avec la maladie de Willebrand?Congrès Français d’Hémostase (CFH), May 2023, St Malo, France
Communication dans un congrès
hal-04459610
v1
|
|
Antibody-based strategies as potential new treatments for von Willebrand Disease65th ASH Annual Meeting, Dec 2023, San Diego, United States
Communication dans un congrès
hal-04459665
v1
|
|
Experimental and clinical rationale for the use of bispecific antibodies in von Willebrand diseaseBari International Conference BIC, Sep 2023, Palerme, Italy
Communication dans un congrès
hal-04459634
v1
|
|
Tailored treatments for VWDEHC Annual Conference, Oct 2021, Virtual conference, Belgium
Communication dans un congrès
hal-04459561
v1
|
|
Future therapies in von Willebrand disease: time for a tailored fit?Bari International Conference BIC, Sep 2021, Venezia, Italy
Communication dans un congrès
hal-04459526
v1
|
|
New Treatment Options for VWDInternational Society of Thrombosis and Haemostasis ISTH, Jul 2021, Philadelphia - online, United States
Communication dans un congrès
hal-04459485
v1
|
|
Vecchi e nuovi percorsi del bus molecolare: il fattore di von WillebrandXXVI SISET, Nov 2020, Baveno - online, Italy
Communication dans un congrès
hal-04459467
v1
|
|
Dégradation du facteur Willebrand et syndrome de Willebrand acquis: Utilisation des dispositifs de support mécaniqueGFHT 2019, Sep 2019, Montpellier, France
Communication dans un congrès
hal-04459451
v1
|
|
|
Von Willebrand disease: from pathophysiology to new therapeutic optionsLife Sciences [q-bio]. University Paris-Saclay, 2022
HDR
tel-04458333
v1
|
|
|
Impact of the COVID‐19 pandemic on education and clinical training2021, pp.2099-2100. ⟨10.1111/jth.15470⟩
Autre publication scientifique
hal-04455705
v1
|
|
|
Exciting times for the ISTH early career professionals2020, pp.2437-2438. ⟨10.1111/jth.15070⟩
Autre publication scientifique
hal-04455572
v1
|
Chargement...
Chargement...